Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
giuseppe.minniti@uniroma1.it
Giuseppe Minniti
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE RADIOLOGICHE, ONCOLOGICHE E ANATOMO-PATOLOGICHE
E-mail:
giuseppe.minniti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Definitive weekly hypofractionated radiotherapy in surgery-ineligible older adults with cutaneous squamous cell carcinoma of the head and neck region
JOURNAL OF GERIATRIC ONCOLOGY
2024
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group
THE LANCET ONCOLOGY
2024
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group
THE LANCET ONCOLOGY
2024
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study
JOURNAL OF NEURO-ONCOLOGY
2024
Response to the letter to the editor by Macià i Garau et al. regarding the article “ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma” by Niyazi et al
RADIOTHERAPY AND ONCOLOGY
2024
Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guideline
RADIOTHERAPY AND ONCOLOGY
2024
Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative
NEURO ONCOLOGY PRACTICE
2024
Response to the letter to the editor by Macià i Garau et al. regarding the article “ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma” by Niyazi et al
RADIOTHERAPY AND ONCOLOGY
2024
Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guideline
RADIOTHERAPY AND ONCOLOGY
2024
Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative
NEURO ONCOLOGY PRACTICE
2024
De Felice scheme: No risk at all of brain radionecrosis?—Authors' reply
HEAD & NECK
2024
Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study
TRIALS
2024
Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery
JOURNAL OF NEURO-ONCOLOGY
2024
ASL, DSC, DCE perfusion MRI and 18F-DOPA PET/CT in differentiating glioma recurrence from post-treatment changes
LA RADIOLOGIA MEDICA
2024
Abscopal Effect on Bone Metastases from Solid Tumors: A Systematic Review and Retrospective Analysis of Challenge within a Challenge
BIOMEDICINES
2023
Radiosurgery for Brain Metastases: Challenges in Imaging Interpretation after Treatment
CANCERS
2023
The Role of Advanced MRI Sequences in the Diagnosis and Follow-Up of Adult Brainstem Gliomas: A Neuroradiological Review
TOMOGRAPHY
2023
Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma
JOURNAL OF NEURO-ONCOLOGY
2023
Feasibility of clinical target volume reduction for glioblastoma treated with standard chemoradiation based on patterns of failure analysis
RADIOTHERAPY AND ONCOLOGY
2023
Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status
JOURNAL OF NEURO-ONCOLOGY
2023
1
2
3
4
5
6
7
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma